Please enable JavaScript to continue using this application.

Compare $CNTN vs $DTIL | Chartloom

Compare

$CNTN vs $DTIL

Canton Strategic Holdings Inc · Precision BioSciences Inc

CNTN

Canton Strategic Holdings Inc

DTIL

Precision BioSciences Inc

Compare $CNTN vs $DTIL

Comparing Canton Strategic Holdings Inc and Precision BioSciences Inc

CNTNCanton Strategic Holdings Inc

DTILPrecision BioSciences Inc

CNTNCanton Strategic Holdings Inc

Market cap

$163M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-37.6%

52W performance

-33.6%

FCF yield

-97.9%

DTILPrecision BioSciences Inc

Market cap

$173M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

80.94x

Rev growth (TTM)

3473.0%

YTD performance

63.9%

52W performance

17.9%

FCF yield

-30.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CNTN

DTIL

Detailed metrics comparison

CNTN

Canton Strategic Holdings Inc

DTIL

Precision BioSciences Inc

Market Cap

CNTN$163M

DTIL$173M

Enterprise Value

CNTN$125M

DTIL$110M

Price

CNTN$2.11

DTIL$6.72

P/E Ratio

CNTNN/A

DTILN/A

P/S Ratio

CNTN108.78x

DTIL3.85x

EV/Sales

CNTN83.88x

DTIL2.44x

EV/EBITDA

CNTN0.00x

DTIL0.00x

P/B Ratio

CNTN0.39x

DTIL3.85x

P/FCF Ratio

CNTNN/A

DTILN/A

EV/FCF

CNTN-0.79x

DTIL-2.09x

PEG Ratio

CNTNN/A

DTILN/A

Forward P/E (NTM)

CNTNN/A

DTILN/A

Forward P/S (NTM)

CNTNN/A

DTIL80.94x

Revenue (TTM)

CNTN$1M

DTIL$45M

Revenue Growth (YoY)

CNTNN/A

DTIL3473.0%

Forward Rev Growth

CNTN0.0%

DTIL-28.2%

Gross Margin (TTM)

CNTN0.0%

DTIL0.0%

Operating Margin (TTM)

CNTN0.0%

DTIL0.0%

EBITDA Margin (TTM)

CNTN-1120.1%

DTIL-78.0%

Net Margin (TTM)

CNTN-6559.1%

DTIL-117.0%

FCF Margin (TTM)

CNTN-10651.0%

DTIL-116.3%

Net Income (TTM)

CNTN$-98M

DTIL$-53M

FCF (TTM)

CNTN$-159M

DTIL$-52M

EPS (TTM)

CNTN-$0.45

DTIL-$2.04

ROE (TTM)

CNTN-2954.0%

DTIL-9160.0%

ROA (TTM)

CNTN-2342.0%

DTIL-4074.0%

ROIC (TTM)

CNTN-2953.0%

DTIL-6594.0%

Cash

CNTN$37M

DTIL$86M

Debt

CNTN$0

DTIL$22M

Net Cash/Debt

CNTN$37M

DTIL$64M

Current Ratio (TTM)

CNTN15.70x

DTIL12.82x

Quick Ratio (TTM)

CNTN14.45x

DTIL12.26x

Debt/Equity (TTM)

CNTN0.00x

DTIL0.50x

Debt/Assets (TTM)

CNTN0.0%

DTIL0.0%

Interest Coverage (TTM)

CNTNN/A

DTILN/A

Net Debt/EBITDA (TTM)

CNTN0.00x

DTIL0.00x

Beta

CNTN1.52

DTIL1.44

52W Performance

CNTN-33.6%

DTIL17.9%

YTD Performance

CNTN-37.6%

DTIL63.9%

% from 52W High

CNTN-69.4%

DTIL-30.1%

% from 52W Low

CNTN20.6%

DTIL90.4%

Asset Turnover (TTM)

CNTN0.00x

DTIL0.36x

FCF Yield (TTM)

CNTN-97.9%

DTIL-30.2%

Earnings Yield (TTM)

CNTN-60.3%

DTIL-30.4%

Dividend Yield (TTM)

CNTNN/A

DTILN/A

Rule of 40

CNTN-10,651.0

DTIL3,356.7

EV/GP/RG

CNTNN/A

DTILN/A

Ticker research

View CNTN research View DTIL research

Metric	CNTN Canton Strategic Holdings Inc	DTIL Precision BioSciences Inc
Market & Valuation
Market Cap	$163M	$173M
Enterprise Value	$125M	$110M
Price	$2.11	$6.72
P/E Ratio	N/A	N/A
P/S Ratio	108.78x	3.85x
EV/Sales	83.88x	2.44x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.39x	3.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.79x	-2.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	80.94x
Revenue & Growth
Revenue (TTM)	$1M	$45M
Revenue Growth (YoY)	N/A	3473.0%
Forward Rev Growth	0.0%	-28.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1120.1%	-78.0%
Net Margin (TTM)	-6559.1%	-117.0%
FCF Margin (TTM)	-10651.0%	-116.3%
Net Income (TTM)	$-98M	$-53M
FCF (TTM)	$-159M	$-52M
EPS (TTM)	-$0.45	-$2.04
ROE (TTM)	-2954.0%	-9160.0%
ROA (TTM)	-2342.0%	-4074.0%
ROIC (TTM)	-2953.0%	-6594.0%
Financial Health
Cash	$37M	$86M
Debt	$0	$22M
Net Cash/Debt	$37M	$64M
Current Ratio (TTM)	15.70x	12.82x
Quick Ratio (TTM)	14.45x	12.26x
Debt/Equity (TTM)	0.00x	0.50x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.52	1.44
52W Performance	-33.6%	17.9%
YTD Performance	-37.6%	63.9%
% from 52W High	-69.4%	-30.1%
% from 52W Low	20.6%	90.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.36x
FCF Yield (TTM)	-97.9%	-30.2%
Earnings Yield (TTM)	-60.3%	-30.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-10,651.0	3,356.7
EV/GP/RG	N/A	N/A
Ticker research	View CNTN research	View DTIL research

Valuation

P/S Ratio

DTIL

3.85x

CNTN

108.78x

EV/FCF

DTIL

-2.09x

CNTN

-0.79x

Growth & revenue

Revenue Growth TTM

DTIL

3473.0%

Forward Revenue Growth

CNTN

0.0%

DTIL

-28.2%

Profitability & performance

Gross Margin

CNTN

0.0%

DTIL

0.0%

ROE

CNTN

-2954.0%

DTIL

-9160.0%

FCF Yield %

DTIL

-30.2%

CNTN

-97.9%

52-Week Performance

DTIL

17.9%

CNTN

-33.6%

Detailed metrics comparison

CNTN

Canton Strategic Holdings Inc

DTIL

Precision BioSciences Inc

Market Cap

CNTN$163M

DTIL$173M

Enterprise Value

CNTN$125M

DTIL$110M

Price

CNTN$2.11

DTIL$6.72

P/E Ratio

CNTNN/A

DTILN/A

P/S Ratio

CNTN108.78x

DTIL3.85x

EV/Sales

CNTN83.88x

DTIL2.44x

EV/EBITDA

CNTN0.00x

DTIL0.00x

P/B Ratio

CNTN0.39x

DTIL3.85x

P/FCF Ratio

CNTNN/A

DTILN/A

EV/FCF

CNTN-0.79x

DTIL-2.09x

PEG Ratio

CNTNN/A

DTILN/A

Forward P/E (NTM)

CNTNN/A

DTILN/A

Forward P/S (NTM)

CNTNN/A

DTIL80.94x

Revenue (TTM)

CNTN$1M

DTIL$45M

Revenue Growth (YoY)

CNTNN/A

DTIL3473.0%

Forward Rev Growth

CNTN0.0%

DTIL-28.2%

Gross Margin (TTM)

CNTN0.0%

DTIL0.0%

Operating Margin (TTM)

CNTN0.0%

DTIL0.0%

EBITDA Margin (TTM)

CNTN-1120.1%

DTIL-78.0%

Net Margin (TTM)

CNTN-6559.1%

DTIL-117.0%

FCF Margin (TTM)

CNTN-10651.0%

DTIL-116.3%

Net Income (TTM)

CNTN$-98M

DTIL$-53M

FCF (TTM)

CNTN$-159M

DTIL$-52M

EPS (TTM)

CNTN-$0.45

DTIL-$2.04

ROE (TTM)

CNTN-2954.0%

DTIL-9160.0%

ROA (TTM)

CNTN-2342.0%

DTIL-4074.0%

ROIC (TTM)

CNTN-2953.0%

DTIL-6594.0%

Cash

CNTN$37M

DTIL$86M

Debt

CNTN$0

DTIL$22M

Net Cash/Debt

CNTN$37M

DTIL$64M

Current Ratio (TTM)

CNTN15.70x

DTIL12.82x

Quick Ratio (TTM)

CNTN14.45x

DTIL12.26x

Debt/Equity (TTM)

CNTN0.00x

DTIL0.50x

Debt/Assets (TTM)

CNTN0.0%

DTIL0.0%

Interest Coverage (TTM)

CNTNN/A

DTILN/A

Net Debt/EBITDA (TTM)

CNTN0.00x

DTIL0.00x

Beta

CNTN1.52

DTIL1.44

52W Performance

CNTN-33.6%

DTIL17.9%

YTD Performance

CNTN-37.6%

DTIL63.9%

% from 52W High

CNTN-69.4%

DTIL-30.1%

% from 52W Low

CNTN20.6%

DTIL90.4%

Asset Turnover (TTM)

CNTN0.00x

DTIL0.36x

FCF Yield (TTM)

CNTN-97.9%

DTIL-30.2%

Earnings Yield (TTM)

CNTN-60.3%

DTIL-30.4%

Dividend Yield (TTM)

CNTNN/A

DTILN/A

Rule of 40

CNTN-10,651.0

DTIL3,356.7

EV/GP/RG

CNTNN/A

DTILN/A

Ticker research

View CNTN research View DTIL research

Metric	CNTN Canton Strategic Holdings Inc	DTIL Precision BioSciences Inc
Market & Valuation
Market Cap	$163M	$173M
Enterprise Value	$125M	$110M
Price	$2.11	$6.72
P/E Ratio	N/A	N/A
P/S Ratio	108.78x	3.85x
EV/Sales	83.88x	2.44x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.39x	3.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.79x	-2.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	80.94x
Revenue & Growth
Revenue (TTM)	$1M	$45M
Revenue Growth (YoY)	N/A	3473.0%
Forward Rev Growth	0.0%	-28.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1120.1%	-78.0%
Net Margin (TTM)	-6559.1%	-117.0%
FCF Margin (TTM)	-10651.0%	-116.3%
Net Income (TTM)	$-98M	$-53M
FCF (TTM)	$-159M	$-52M
EPS (TTM)	-$0.45	-$2.04
ROE (TTM)	-2954.0%	-9160.0%
ROA (TTM)	-2342.0%	-4074.0%
ROIC (TTM)	-2953.0%	-6594.0%
Financial Health
Cash	$37M	$86M
Debt	$0	$22M
Net Cash/Debt	$37M	$64M
Current Ratio (TTM)	15.70x	12.82x
Quick Ratio (TTM)	14.45x	12.26x
Debt/Equity (TTM)	0.00x	0.50x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.52	1.44
52W Performance	-33.6%	17.9%
YTD Performance	-37.6%	63.9%
% from 52W High	-69.4%	-30.1%
% from 52W Low	20.6%	90.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.36x
FCF Yield (TTM)	-97.9%	-30.2%
Earnings Yield (TTM)	-60.3%	-30.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-10,651.0	3,356.7
EV/GP/RG	N/A	N/A
Ticker research	View CNTN research	View DTIL research